Title |
Amyloid-beta transporter expression at the blood-CSF barrier is age-dependent
|
---|---|
Published in |
Fluids and Barriers of the CNS, July 2011
|
DOI | 10.1186/2045-8118-8-21 |
Pubmed ID | |
Authors |
Crissey L Pascale, Miles C Miller, Catherine Chiu, Matthew Boylan, Ilias N Caralopoulos, Liliana Gonzalez, Conrad E Johanson, Gerald D Silverberg |
Abstract |
Age is the major risk factor for many neurodegenerative diseases, including Alzheimer's disease (AD). There is an accumulation of amyloid-beta peptides (Aβ) in both the AD brain and the normal aging brain. Clearance of Aβ from the brain occurs via active transport at the blood-brain barrier (BBB) and blood-cerebrospinal fluid barrier (BCSFB). With increasing age, the expression of the Aβ efflux transporters is decreased and the Aβ influx transporter expression is increased at the BBB, adding to the amyloid burden in the brain. Expression of the Aβ transporters at the choroid plexus (CP) epithelium as a function of aging was the subject of this study. |
X Demographics
Geographical breakdown
Country | Count | As % |
---|---|---|
United States | 1 | 100% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Members of the public | 1 | 100% |
Mendeley readers
Geographical breakdown
Country | Count | As % |
---|---|---|
Iran, Islamic Republic of | 1 | <1% |
United States | 1 | <1% |
France | 1 | <1% |
Unknown | 112 | 97% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Student > Ph. D. Student | 22 | 19% |
Researcher | 17 | 15% |
Student > Bachelor | 17 | 15% |
Student > Master | 13 | 11% |
Student > Doctoral Student | 6 | 5% |
Other | 22 | 19% |
Unknown | 18 | 16% |
Readers by discipline | Count | As % |
---|---|---|
Agricultural and Biological Sciences | 32 | 28% |
Neuroscience | 18 | 16% |
Medicine and Dentistry | 14 | 12% |
Biochemistry, Genetics and Molecular Biology | 11 | 10% |
Pharmacology, Toxicology and Pharmaceutical Science | 7 | 6% |
Other | 14 | 12% |
Unknown | 19 | 17% |